Scientists have discovered what could be a breakthrough in the treatment of Alzheimer’s disease. Over 7 million Americans are living with Alzheimer’s, which slowly erodes memory, cognitive skills and ...

Scientists have found a potential new treatment target for Alzheimer’s. It comes after a novel technique improved cognitive function in mice with the disease. Alzheimer’s disease is thought to be ...

One of the most heartbreaking occurrences for nature lovers is to discover a beached marine mammal such as a dolphin or whale. If the animal is still alive, marine biologists assisted by citizen ...

A new study reveals innovative nanotechnology that restored the function of the blood-brain barrier to reverse Alzheimer's disease in mice. Scientists have discovered what could be a breakthrough in ...

A Washington man appeared to be destined to develop Alzheimer’s disease — but against all genetic odds, he has eluded the common dementia for decades. Researchers at the Washington University School ...

Researchers have identified a gene that they reported was linked to a 1.5 times-higher likelihood of suffering from Alzheimer’s disease. In the first large-scale trial of brains afflicted by the ...

Scientists have achieved a “striking” reversal of Alzheimer’s disease in mice by restoring the normal function of the brain's vasculature—the network of blood vessels that supplies it with oxygen and ...

ST. PAUL, Minn., Oct. 6 (UPI) --Spanish and Chinese scientists said Monday they have used specifically tailored nanoparticles to clear out build-ups of a key toxin linked to Alzheimer's disease in the ...

A team of scientists at Texas Tech University Health Sciences Center (TTUHSC) has published new evidence suggesting that the brain's protective shield—known as the blood-brain barrier (BBB)—remains ...

BILOXI, Miss. (WLOX) - The community came together in Biloxi to join the fight against Alzheimer’s. The annual Walk to End Alzheimer’s took over Point Cadet Plaza, with hundreds coming out in support.

The anti-MTBR-tau-targeting antibody was associated with reductions in tau uptake and spread in preclinical data. The Food and Drug Administration (FDA) has granted Fast Track designation to Bristol ...